The evolving use of arsenic in pharmacotherapy of malignant disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The evolving use of arsenic in pharmacotherapy of malignant disease
Authors
Keywords
Arsenic trioxide, Pharmacology, Metabolism, Toxicity, Malignancy
Journal
ANNALS OF HEMATOLOGY
Volume 92, Issue 6, Pages 719-730
Publisher
Springer Nature
Online
2013-03-14
DOI
10.1007/s00277-013-1707-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arsenic trioxide for refractory aplastic anemia
- (2012) Quande Lin et al. ANNALS OF HEMATOLOGY
- Carbonyl Reductase 1 Offers a Novel Therapeutic Target to Enhance Leukemia Treatment by Arsenic Trioxide
- (2012) Miran Jang et al. CANCER RESEARCH
- Revisiting the differentiation paradigm in acute promyelocytic leukemia
- (2011) J. Ablain et al. BLOOD
- Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study
- (2011) W.-Y. Au et al. BLOOD
- Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged
- (2011) Meir Wetzler et al. CANCER
- Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells
- (2011) Ubaldo E. Martinez-Outschoorn et al. CANCER BIOLOGY & THERAPY
- Exploring Old Drugs for the Treatment of Hematological Malignancies
- (2011) F. Gan et al. CURRENT MEDICINAL CHEMISTRY
- Arsenic trioxide inhibits invasion/migration in SGC-7901 cells by activating the reactive oxygen species-dependent cyclooxygenase-2/matrix metalloproteinase-2 pathway
- (2011) Yingxia Liu et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina
- (2011) Laura Rosana Aballay et al. INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH
- Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
- (2011) Ardeshir Ghavamzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on human leukemic cell lines
- (2011) M. Stępnik et al. MEDICAL ONCOLOGY
- Targeting SP1 Transcription Factor in Prostate Cancer Therapy
- (2011) Umesh T. Sankpal et al. Medicinal Chemistry
- Involvement of Glycogen Synthase Kinase-3β in Arsenic Trioxide–Induced p21 Expression
- (2011) Huei-Sheng Huang et al. TOXICOLOGICAL SCIENCES
- Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
- (2010) B. L. Powell et al. BLOOD
- The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel
- (2010) Qian Liu et al. BMC Medical Genomics
- Development of target-specific treatments in multiple myeloma
- (2010) Asher A. Chanan-Khan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation
- (2010) Youhong Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia
- (2010) Steven D. Gore et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
- (2010) Vikram Mathews et al. JOURNAL OF CLINICAL ONCOLOGY
- Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
- (2010) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Arsenic trioxide promotes mitochondrial DNA mutation and cell apoptosis in primary APL cells and NB4 cell line
- (2010) Ran Meng et al. Science China-Life Sciences
- Arsenic, Stem Cells, and the Developmental Basis of Adult Cancer
- (2010) E. J. Tokar et al. TOXICOLOGICAL SCIENCES
- Interspecies differences in metabolism of arsenic by cultured primary hepatocytes
- (2010) Zuzana Drobná et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- How I treat acute promyelocytic leukemia
- (2009) M. S. Tallman et al. BLOOD
- The hedgehog pathway as a therapeutic target for treatment of breast cancer
- (2009) M. F. Barginear et al. BREAST CANCER RESEARCH AND TREATMENT
- Notoriety to respectability: a short history of arsenic prior to its present day use in haematology
- (2009) Derek Doyle BRITISH JOURNAL OF HAEMATOLOGY
- From the desk of the guest editor
- (2009) SujitRanjan Sengupta Indian Journal of Dermatology Venereology & Leprology
- Arsenicosis: Diagnosis and treatment
- (2009) NilayKanti Das et al. Indian Journal of Dermatology Venereology & Leprology
- Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition
- (2009) Jianguo Wen et al. LEUKEMIA RESEARCH
- Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells
- (2009) H. M. Pettersson et al. MOLECULAR CANCER THERAPEUTICS
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential cytotoxic effects of arsenic compounds in human acute promyelocytic leukemia cells
- (2009) Vichaya Charoensuk et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- New drugs in multiple myeloma
- (2009) James R Berenson et al. Current Opinion in Supportive and Palliative Care
- Metabolism and the Paradoxical Effects of Arsenic: Carcinogenesis and Anticancer
- (2008) Xing Cui et al. CURRENT MEDICINAL CHEMISTRY
- Arsenic Exposure and Prevalence of Type 2 Diabetes in US Adults
- (2008) Ana Navas-Acien JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer)
- (2008) Araceli Hernández-Zavala et al. JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
- Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
- (2008) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003–2004
- (2008) Kathleen L Caldwell et al. Journal of Exposure Science and Environmental Epidemiology
- Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2 -terminal MAPK but not extracellular signal-regulated kinases-1/2
- (2008) François Binet et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13
- (2008) Olaf Merkel et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Mineral Arsenicals in Traditional Medicines: Orpiment, Realgar, and Arsenolite
- (2008) J. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Arsenic trioxide mechanisms of action – looking beyond acute promyelocytic leukemia
- (2008) Dennis A. Carney LEUKEMIA & LYMPHOMA
- Arsenic trioxide decreases AKT protein in a caspase-dependent manner
- (2008) Koren K. Mann et al. MOLECULAR CANCER THERAPEUTICS
- Arsenic trioxide mutational spectrum analysis in the mouse lymphoma assay
- (2008) Carolina Soriano et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Arsenic metabolism is influenced by polymorphisms in genes involved in one-carbon metabolism and reduction reactions
- (2008) Karin Schläwicke Engström et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Toxicogenomics of arsenic: Classical ideas and recent advances
- (2008) P GHOSH et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Genetic variations associated with interindividual sensitivity in the response to arsenic exposure
- (2008) Alba Hernández et al. PHARMACOGENOMICS
- Arsenic trioxide phosphorylates c-Fos to transactivate p21WAF1/CIP1 expression
- (2008) Zi-Miao Liu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Ethnic differences in five intronic polymorphisms associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene
- (2008) Junko Fujihara et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma
- (2008) Chia-Chi Lin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Analytical artefacts in the speciation of arsenic in clinical samples
- (2007) Zdenka Šlejkovec et al. ANALYTICA CHIMICA ACTA
- Role of the Met287Thr polymorphism in the AS3MT gene on the metabolic arsenic profile
- (2007) Alba Hernández et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started